Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mycobacterium kyorinense infection.
Ohnishi H, Yonetani S, Matsushima S, Wada H, Takeshita K, Kuramochi D, Caldas PC, Campos CE, da Costa BP, Ramos JP, Mikura S, Narisawa E, Fujita A, Funayama Y, Kobashi Y, Sakakibara Y, Ishiyama Y, Takakura S, Goto H, Watanabe T. Ohnishi H, et al. Among authors: funayama y. Emerg Infect Dis. 2013 Mar;19(3):508-10. doi: 10.3201/eid1903.12-0591. Emerg Infect Dis. 2013. PMID: 23750358 Free PMC article. No abstract available.
Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study.
Okauchi S, Numata T, Nawa T, Ichimura H, Saito T, Hayashihara K, Yamada H, Satoh H, Endo T, Inage Y, Kaburagi T, Kiyoshima M, Yamada Y, Tamura T, Saito K, Inagaki M, Hizawa N, Sato Y, Shiozawa T, Sekine I, Ishikawa H, Kurihima K, Sakai M, Kamiyama K, Kimura M, Kikuchi N, Nakamura H, Furukawa K, Kodama T, Miyazaki K, Yamashita T, Hayashi S, Funayama Y, Nomura A. Okauchi S, et al. Among authors: funayama y. Anticancer Res. 2020 Feb;40(2):957-964. doi: 10.21873/anticanres.14029. Anticancer Res. 2020. PMID: 32014940
Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR-mutated Non-small Cell Lung Cancer.
Shiozawa T, Numata T, Tamura T, Endo T, Kaburagi T, Yamamoto Y, Yamada H, Kikuchi N, Saito K, Inagaki M, Kurishima K, Funayama Y, Miyazaki K, Koyama N, Furukawa K, Nakamura H, Kikuchi S, Ichimura H, Sato Y, Sekine I, Satoh H, Hizawa N. Shiozawa T, et al. Among authors: funayama y. Anticancer Res. 2022 May;42(5):2583-2590. doi: 10.21873/anticanres.15736. Anticancer Res. 2022. PMID: 35489768
Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice.
Yamada Y, Tamura T, Yamamoto Y, Ichimura H, Hayashihara K, Saito T, Yamada H, Endo T, Nakamura R, Inage Y, Satoh H, Iguchi K, Saito K, Inagaki M, Kikuchi N, Kurishima K, Ishikawa H, Sakai M, Kamiyama K, Shiozawa T, Hizawa N, Sekine I, Sato Y, Funayama Y, Miyazaki K, Kodama T, Hayashi S, Nomura A, Nakamura H, Furukawa K, Yamashita T, Okubo H, Suzuki H, Kiyoshima M, Kaburagi T. Yamada Y, et al. Among authors: funayama y. Anticancer Res. 2020 Oct;40(10):5757-5764. doi: 10.21873/anticanres.14592. Anticancer Res. 2020. PMID: 32988903 Clinical Trial.
Serum CEA and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis.
Numata T, Endo T, Yanai H, Ota K, Yamamoto Y, Shimizu K, Yamada H, Hayashihara K, Okauchi S, Satoh H, Yamada Y, Tamura T, Saito K, Kikuchi N, Kurishima K, Ishikawa H, Watanabe H, Shiozawa T, Hizawa N, Funayama Y, Hayashi S, Nakamura H, Yamashita T. Numata T, et al. Among authors: funayama y. In Vivo. 2020 Jul-Aug;34(4):2095-2100. doi: 10.21873/invivo.12013. In Vivo. 2020. PMID: 32606188 Free PMC article.
Management of small cell lung cancer in elderly.
Satoh H, Ishikawa H, Funayama Y, Yamashita YT, Kamma H, Ohtsuka M, Sekizawa K. Satoh H, et al. Among authors: funayama y. Anticancer Res. 1999 Sep-Oct;19(5C):4507-10. Anticancer Res. 1999. PMID: 10650801
Endostatin levels in exudative pleural effusions.
Sumi M, Kagohashi K, Satoh H, Ishikawa H, Funayama Y, Sekizawa K. Sumi M, et al. Among authors: funayama y. Lung. 2003 Nov-Dec;181(6):329-34. doi: 10.1007/s00408-003-1035-9. Lung. 2003. PMID: 14749937
192 results